Diabetes & Glucose
Type 1 Diabetes Mellitus (T1DM)
• Autoimmune destruction of pancreatic β-cells → absolute insulin deficiency
• Typically presents in childhood/adolescence
• Features: polyuria, polydipsia, weight loss, ketosis, DKA
• Associated with other autoimmune diseases (e.g. coeliac, thyroid)
• Requires lifelong insulin therapy
• Antibodies: anti-GAD, anti-IA2, ZnT8
Type 2 Diabetes Mellitus (T2DM)
• Combination of insulin resistance and relative insulin deficiency
• Risk factors: obesity, family history, sedentary lifestyle, South Asian/Afro-Caribbean ethnicity
• Often asymptomatic or mild osmotic symptoms
• Management (stepwise):
1. Lifestyle modification
2. Metformin (1st-line, unless contraindicated)
3. Add SGLT2 inhibitor or GLP-1 RA (if CVD/weight loss benefit)
4. Add insulin or SU/DPP4i if needed
Diagnosis of Diabetes
• Any one of the following (in symptomatic patients):
o HbA1c ≥ 48 mmol/mol (6.5%)
o Fasting glucose ≥ 7.0 mmol/L
o 2h glucose ≥ 11.1 mmol/L on OGTT
o Random glucose ≥ 11.1 mmol/L with symptoms
• If asymptomatic: confirm with second abnormal test
Secondary Diabetes
• Pancreatic: chronic pancreatitis, haemochromatosis, pancreatic cancer
• Endocrine: Cushing’s syndrome, acromegaly, phaeochromocytoma, glucagonoma
• Drug-induced: steroids, antipsychotics, thiazide diuretics
MODY (Maturity-Onset Diabetes of the Young)
• Monogenic (AD) form of non-insulin dependent diabetes
• Onset <25 years, strong FHx, not obese
• Often misdiagnosed as T1/T2
• Subtypes:
o HNF1A/4A: sensitive to sulfonylureas
o GCK: mild stable fasting hyperglycaemia, no treatment needed
Complications of Diabetes
• Microvascular:
o Retinopathy: background → pre-proliferative → proliferative ± maculopathy
o Nephropathy: microalbuminuria → proteinuria → CKD
o Neuropathy: distal symmetrical sensory loss ("glove and stocking")
• Macrovascular:
o ↑ risk of MI, stroke, PAD
• Autonomic neuropathy:
o Gastroparesis, erectile dysfunction, postural hypotension, bladder dysfunction
• Prevention: tight glucose, BP, lipid control; annual screening
Diabetes in Pregnancy
• Includes gestational diabetes and pre-existing diabetes
• Risks: macrosomia, pre-eclampsia, neonatal hypoglycaemia
• Insulin is treatment of choice
• Oral hypoglycaemics usually stopped (some units use metformin)
• Monitor closely with growth scans and glucose targets